Literature DB >> 9557687

Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.

A Mathew1, I Kurane, S Green, H A Stephens, D W Vaughn, S Kalayanarooj, S Suntayakorn, D Chandanayingyong, F A Ennis, A L Rothman.   

Abstract

We examined the memory cytotoxic T-lymphocytic (CTL) responses of peripheral blood mononuclear cells (PBMC) obtained from patients in Thailand 12 months after natural symptomatic secondary dengue virus infection. In all four patients analyzed, CTLs were detected in bulk culture PBMC against nonstructural dengue virus proteins. Numerous CD4+ and CD8+ CTL lines were generated from the bulk cultures of two patients, KPP94-037 and KPP94-024, which were specific for NS1.2a (NS1 and NS2a collectively) and NS3 proteins, respectively. All CTL lines derived from both patients were cross-reactive with other serotypes of dengue virus. The CD8+ NS1.2a-specific lines from patient KPP94-037 were HLA B57 restricted, and the CD8+ NS3-specific lines from patient KPP94-024 were HLA B7 restricted. The CD4+ CTL lines from patient KPP94-037 were HLA DR7 restricted. A majority of the CD8+ CTLs isolated from patient KPP94-024 were found to recognize amino acids 221 to 232 on NS3. These results demonstrate that in Thai patients after symptomatic secondary natural dengue infections, CTLs are mainly directed against nonstructural proteins and are broadly cross-reactive.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557687      PMCID: PMC109627          DOI: 10.1128/JVI.72.5.3999-4004.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

Review 1.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.

Authors:  J Sidney; H M Grey; R T Kubo; A Sette
Journal:  Immunol Today       Date:  1996-06

2.  HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais.

Authors:  D Chandanayingyong; H A Stephens; R Klaythong; M Sirikong; S Udee; P Longta; R Chantangpol; S Bejrachandra; E Rungruang
Journal:  Hum Immunol       Date:  1997-04-01       Impact factor: 2.850

3.  Establishment of dengue virus-specific human CD4+ T lymphocyte clones from Percoll-purified T lymphoblasts by stimulation with monoclonal antibody to CD3.

Authors:  J Zivny; I Kurane; F A Ennis
Journal:  J Immunol Methods       Date:  1995-12-15       Impact factor: 2.303

4.  Histocompatibility antigens and dengue hemorrhagic fever.

Authors:  P Chiewsilp; R M Scott; N Bhamarapravati
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

5.  Early clinical and laboratory indicators of acute dengue illness.

Authors:  S Kalayanarooj; D W Vaughn; S Nimmannitya; S Green; S Suntayakorn; N Kunentrasai; W Viramitrachai; S Ratanachu-eke; S Kiatpolpoj; B L Innis; A L Rothman; A Nisalak; F A Ennis
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.

Authors:  A Mathew; I Kurane; A L Rothman; L L Zeng; M A Brinton; F A Ennis
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

7.  Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; W Zeng; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

9.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.

Authors:  S B Halstead; S Nimmannitya; S N Cohen
Journal:  Yale J Biol Med       Date:  1970-04
View more
  45 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.

Authors:  A V Timofeev; V M Butenko; J R Stephenson
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

3.  Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.

Authors:  Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 4.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

5.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

6.  Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.

Authors:  Katherine M Mladinich; Shari M Piaskowski; Richard Rudersdorf; Christopher M Eernisse; Kim L Weisgrau; Mauricio A Martins; Jessica R Furlott; Charalambos D Partidos; Joseph N Brewoo; Jorge E Osorio; Nancy A Wilson; Eva G Rakasz; David I Watkins
Journal:  Immunogenetics       Date:  2011-09-01       Impact factor: 2.846

7.  Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence.

Authors:  Chunlin Zhang; Mammen P Mammen; Piyawan Chinnawirotpisan; Chonticha Klungthong; Prinyada Rodpradit; Patama Monkongdee; Suchitra Nimmannitya; Siripen Kalayanarooj; Edward C Holmes
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 8.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

9.  Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells.

Authors:  Zu T Shen; Tina T Nguyen; Keith A Daniels; Raymond M Welsh; Lawrence J Stern
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

Review 10.  Plasma leakage in dengue haemorrhagic fever.

Authors:  Anon Srikiatkhachorn
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.